Can you explain chronic pancreatitis, including its etiology, clinical presentation, and management?

Chronic Pancreatitis Overview

Chronic pancreatitis is an irreversible fibro-inflammatory disease of the pancreas that results in progressive structural damage, leading to varying degrees of chronic pain, exocrine pancreatic insufficiency, and endocrine insufficiency (diabetes mellitus). 1

Etiology

The causes of chronic pancreatitis follow the TIGAR-O classification system:

• Toxic-metabolic: Alcohol (most common in Western countries), tobacco smoking, hypercalcemia, hypertriglyceridemia
• Idiopathic: Early-onset (younger patients) or late-onset (older patients), accounting for 8-30% of cases 2
• Genetic: Mutations in PRSS1, SPINK1, CFTR genes (associated with significantly higher pancreatic cancer risk) 2
• Autoimmune: IgG4-related disease
• Recurrent acute pancreatitis: Approximately 35% of patients with recurrent acute pancreatitis progress to chronic pancreatitis 1
• Obstructive: Pancreatic duct stones, strictures, tumors, pancreas divisum

Clinical Presentation

Pain Characteristics

• Chronic abdominal pain is the predominant symptom, typically epigastric radiating to the back
• Pain occurs more frequently in early-onset idiopathic CP compared to alcoholic CP 2
• Pain is multifactorial: pancreatic duct obstruction, increased intraductal pressure, pancreatic duct stones, strictures, inflammatory mass effect, and central sensitization 3

Exocrine Insufficiency Manifestations 4

• Steatorrhea (fatty, foul-smelling stools) with or without diarrhea
• Weight loss and protein-calorie malnutrition
• Bloating and excessive flatulence
• Fat-soluble vitamin deficiencies (A, D, E, K)
• Metabolic bone disease

Endocrine Insufficiency

• Diabetes mellitus develops as pancreatic islet cells are destroyed
• Occurs faster in late-onset idiopathic CP than in alcoholic or early-onset forms 2

Associated Complications 5

• Pancreatic pseudocysts
• Biliary strictures causing obstructive jaundice
• Duodenal obstruction
• Vascular complications (splenic vein thrombosis, pseudoaneurysms)
• Significantly increased risk of pancreatic ductal adenocarcinoma, especially with genetic mutations 2

Psychosocial Impact

• High rates of depression and anxiety complicate the clinical picture 3
• Significant disability and decreased quality of life
• High healthcare utilization 1

Diagnostic Approach

Initial Evaluation

Obtain comprehensive personal and family history focusing on:

• Alcohol consumption patterns and tobacco use
• Previous episodes of acute pancreatitis
• Family history of pancreatic disease
• Medication review
• Laboratory testing: liver biochemistries, triglycerides, calcium levels 1

Imaging Studies

First-line imaging 6:

• CT scan or MRI with MRCP to identify pancreatic calcifications, ductal dilation, atrophy, and structural changes
• These modalities cannot directly identify exocrine insufficiency but diagnose underlying pancreatic disease 4

Advanced diagnostic tools:

• Endoscopic ultrasound (EUS) is the most important tool for evaluating unexplained cases, with diagnostic yield of 29-88% 1
• EUS allows tissue sampling to exclude malignancy (critical as 5-12% of recurrent acute pancreatitis cases harbor occult malignancy) 1

Testing for Exocrine Pancreatic Insufficiency

Fecal elastase is the most appropriate initial test 4:

• Must be performed on semi-solid or solid stool specimen
• <100 mg/g confirms EPI; 100-200 mg/g is indeterminate
• Can be performed while patient is on pancreatic enzyme replacement therapy
• Fecal fat testing is rarely needed and impractical for routine use

Important caveat: Response to therapeutic trial of pancreatic enzymes is unreliable for diagnosis 4

Management Strategy

Pain Management Algorithm

1. Behavioral Modifications (First-line):

• Mandatory alcohol cessation and smoking cessation 6
• These interventions slow disease progression

2. Medical Pain Management:

• Start with nonopioid analgesics 6
• Avoid routine celiac plexus block—it should NOT be routinely performed due to unclear outcomes and procedural risks 1
• Consider celiac plexus block only in selected patients with debilitating pain after other measures have failed, on a case-by-case basis 1

3. Endoscopic vs. Surgical Intervention for Obstructive Disease:

Surgical intervention should be considered over endoscopic therapy for long-term treatment of painful obstructive chronic pancreatitis 1. This is the guideline-recommended approach.

• Early surgery (<3 years from symptom onset) has superior outcomes compared to late surgery 6
• Duodenal-preserving strategies are preferred unless malignancy is suspected 6

Endoscopic therapy is reasonable for:

• Suboptimal surgical candidates
• Patients preferring less invasive approach (after informed discussion that surgery is preferred) 1

Specific Endoscopic Interventions (When Pursued)

For pancreatic duct stones 1:

• Small stones (≤5mm): Conventional extraction via ERCP
• Large stones: Extracorporeal shockwave lithotripsy (ESWL) and/or pancreatoscopy with intraductal lithotripsy

For pancreatic duct strictures 1:

• Prolonged stent therapy (6-12 months) is effective
• Preferred approach: Sequential addition of multiple plastic stents in parallel (upsizing)
• Fully covered self-expanding metal stents may have a role but need more research

For biliary strictures 1:

• ERCP with stent insertion is the preferred treatment
• Fully covered self-expanding metal stents (FCSEMS) are favored over multiple plastic stents when feasible (similar efficacy, reduced need for exchanges)

Management of Exocrine Pancreatic Insufficiency

Once EPI is diagnosed, treatment with pancreatic enzyme replacement therapy (PERT) is required 4:

• Initial dose: 40,000-50,000 USP units of lipase with each meal in adults
• Half that dose with snacks
• Take enzymes during the meal, not before or after
• All PERT formulations are porcine-derived and equally effective at equivalent doses 4
• Non-enteric-coated preparations require H2 blocker or proton pump inhibitor co-administration
• Adjust dosage based on clinical response

Untreated EPI leads to:

• Fat malabsorption complications
• Malnutrition
• Negative impact on quality of life 4

Management of Endocrine Insufficiency

• Standard diabetes management principles apply
• Monitor for development of diabetes as disease progresses

Nutritional Support

• Supplemental fat-soluble vitamins (A, D, E, K)
• Address protein-calorie malnutrition
• Dietitian consultation for optimization

High-Risk Populations Requiring Surveillance

Suspect EPI in high-risk conditions 4:

• Chronic pancreatitis (any etiology)
• Relapsing acute pancreatitis
• Pancreatic ductal adenocarcinoma
• Cystic fibrosis
• Previous pancreatic surgery

Consider EPI in moderate-risk conditions 4:

• Celiac disease and Crohn's disease
• Previous intestinal surgery
• Long-standing diabetes mellitus
• Hypersecretory states (Zollinger-Ellison syndrome)

Critical Pitfalls to Avoid

• Do not delay surgical referral in appropriate candidates with painful obstructive disease—surgery is superior to endoscopy for long-term outcomes 1
• Do not routinely perform celiac plexus blocks for pain management 1
• Do not perform fecal elastase on liquid stool—results will be falsely low 4
• Do not rely on therapeutic trial of enzymes to diagnose EPI 4
• Do not miss occult malignancy—maintain high suspicion, especially in unexplained cases and those with genetic mutations 2
• Address psychosocial factors (depression, anxiety) as integral components of comprehensive care 3